Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEGARELIX vs DELAFLOXACIN MEGLUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEGARELIX vs DELAFLOXACIN MEGLUMINE: Safety Overview

Metric DEGARELIX DELAFLOXACIN MEGLUMINE
Total FAERS Reports 3,779 234
Deaths Reported 484 4
Death Rate 12.8% 1.7%
Hospitalizations 1,333 17
Average Patient Age 74.0 yrs 61.6 yrs
% Female Patients 0.7% 47.4%
FDA Approval Date Dec 24, 2008 Jun 19, 2017
Manufacturer Ferring Pharmaceuticals Inc. Melinta Therapeutics, LLC
Route N/A ORAL
Marketing Status Prescription Prescription